205 related articles for article (PubMed ID: 16790654)
1. General anesthesia and chronic amphetamine use: should the drug be stopped preoperatively?
Fischer SP; Schmiesing CA; Guta CG; Brock-Utne JG
Anesth Analg; 2006 Jul; 103(1):203-6, table of contents. PubMed ID: 16790654
[TBL] [Abstract][Full Text] [Related]
2. Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
Whitley HP; Moorman KL
Pharmacotherapy; 2007 Oct; 27(10):1440-5. PubMed ID: 17896898
[TBL] [Abstract][Full Text] [Related]
3. General anesthesia in a patient on long-term amphetamine therapy: is there cause for concern?
Fischer SP; Healzer JM; Brook MW; Brock-Utne JG
Anesth Analg; 2000 Sep; 91(3):758-9. PubMed ID: 10960415
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder.
Cartabuke RS; Tobias JD; Rice J; Tumin D
Paediatr Anaesth; 2017 Apr; 27(4):417-424. PubMed ID: 28181385
[TBL] [Abstract][Full Text] [Related]
5. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
6. ECGs before stimulants in children.
Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112
[No Abstract] [Full Text] [Related]
7. [General anesthesia for two patients taking methylphenidate (Ritalin)].
Kasuga T; Meno A; Honda M; Momoeda K; Nagase M; Hanaoka K
Masui; 2008 Jun; 57(6):748-51. PubMed ID: 18546908
[TBL] [Abstract][Full Text] [Related]
8. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
9. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
Faraone SV; Wigal SB; Hodgkins P
J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic stroke in a patient recently started on mixed amphetamine salts.
Kapetanovic S; Kim MA
Am J Psychiatry; 2010 Oct; 167(10):1277-8. PubMed ID: 20889668
[No Abstract] [Full Text] [Related]
11. Relationship between amphetamine ingestion and gingival enlargement.
Hasan AA; Ciancio S
Pediatr Dent; 2004; 26(5):396-400. PubMed ID: 15460293
[TBL] [Abstract][Full Text] [Related]
12. Day case general anaesthesia in a patient with narcolepsy.
Doyle A; Wilkinson D
Anaesthesia; 2008 Aug; 63(8):880-2. PubMed ID: 18518866
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
14. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
15. ADHD black box warning: how concerned should we be?
Cruz R; Kutscher EC
S D Med; 2007 Feb; 60(2):63, 65. PubMed ID: 17390569
[No Abstract] [Full Text] [Related]
16. Myocardial infarction associated with adderall XR and alcohol use in a young man.
Jiao X; Velez S; Ringstad J; Eyma V; Miller D; Bleiberg M
J Am Board Fam Med; 2009; 22(2):197-201. PubMed ID: 19264944
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
Torres AR; Whitney J; Gonzalez-Heydrich J
Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine, mazindol, and fencamfamin in narcolepsy.
Shindler J; Schachter M; Brincat S; Parkes JD
Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077
[TBL] [Abstract][Full Text] [Related]
19. Medications for adolescents with attention-deficit/hyperactivity disorder.
Soileau EJ
Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
[TBL] [Abstract][Full Text] [Related]
20. Hidden amphetamines: from smoking cessation to diabetes.
Prescrire Int; 2004 Feb; 13(69):18-20. PubMed ID: 15055218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
